Abstract
The subunit composition of GABAA receptors influences their biophysical and pharmacological properties, dictates neuronal location and the interaction with associated proteins, and markedly influences the impact of intracellular biochemistry. The focus has been on α and γ subunits, with little attention given to β subunits. Dentate gyrus granule cells (DGGCs) express all three β subunit isoforms and exhibit both synaptic and extrasynaptic receptors that mediate ‘phasic’ and ‘tonic’ transmission, respectively. To investigate the subcellular distribution of the β subunits we have utilized the patch-clamp technique to compare the properties of ‘tonic’ and miniature inhibitory postsynaptic currents (mIPSCs) recorded from DGGCs of hippocampal slices of P20–26 wild-type (WT), β2−/−, β2N265S (etomidate-insensitive), α1−/− and δ−/− mice. Deletion of either the β2 or the δ subunit produced a significant reduction of the tonic current and attenuated the increase of this current induced by the δ subunit-preferring agonist 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP). By contrast, mIPSCs were not influenced by deletion of these genes. Enhancement of the tonic current by the β2/3 subunit-selective agent etomidate was significantly reduced for DGGCs derived from β2N265S mice, whereas this manipulation had no effect on the prolongation of mIPSCs produced by this anaesthetic. Collectively, these observations, together with previous studies on α4−/− mice, identify a population of extrasynaptic α4β2δ receptors, whereas synaptic GABAA receptors appear to primarily incorporate the β3 subunit. A component of the tonic current is diazepam sensitive and is mediated by extrasynaptic receptors incorporating α5 and γ2 subunits. Deletion of the β2 subunit had no effect on the diazepam-induced current and therefore these extrasynaptic receptors do not contain this subunit. The unambiguous identification of these distinct pools of synaptic and extrasynaptic GABAA receptors should aid our understanding of how they act in harmony, to regulate hippocampal signalling in health and disease.
In mammalian brain, ‘fast’ neuronal inhibition is predominantly mediated by γ-aminobutyric acid (GABA), acting to transiently activate synaptic ionotropic GABAA receptors and cause ‘phasic’ inhibition. However, in some neurones, GABA additionally activates a topographically discrete pool of extrasynaptic receptors to mediate a persistent ‘tonic’ form of inhibition, which functions in partnership with phasic inhibition, to influence neuronal excitability (Farrant & Nusser, 2005; Walker & Semyanov, 2007). In certain neurones phasic and tonic inhibition are mediated by distinct GABAA receptor isoforms, with each subtype assembled from a possible palette of 19 subunits (α1–6, β1-3, γ1-3, δ, θ, π, ɛ, ρ1-3) to form a pentamer. Such receptor isoforms have distinct physiological and pharmacological properties and their expression may be differentially influenced by psychiatric and neurological disorders (Fritschy & Brunig, 2003; Whiting, 2003; Mohler, 2007).
Although receptors incorporating the γ2 subunit may occur both synaptically and extrasynaptically (Devor et al. 2001; Caraiscos et al. 2004; Luscher & Keller, 2004; Zhang et al. 2007), δ-subunit-containing receptors are primarily located extra- or peri-synaptically (Nusser et al. 1998; Wei et al. 2003). For dentate gyrus granule cells (DGGCs) and thalamocortical relay neurones, the α4 subunit is the principal δ-subunit partner (Wisden et al. 1992; Sur et al. 1999; Chandra et al. 2006), whereas in cerebellar granule cells (CGCs) and particular hippocampal interneurones, it coassembles with α6 and α1 subunits, respectively (Nusser et al. 1998; Glykys et al. 2007). By contrast, relatively little is known regarding the identity of the β subunit isoforms that coassemble with the δ subunit. However, this issue is of considerable physiological importance, given that several intracellular proteins, known to regulate receptor trafficking, membrane insertion and surface stability, can differentially interact with different β subunit isoforms (Chen & Olsen, 2007; Michels & Moss, 2007). Furthermore, the large intracellular loop of the β subunit can be phosphorylated by a variety of kinases, in an isoform selective manner, to consequently influence the trafficking and function of GABAA receptors (Brandon et al. 2003; Kittler & Moss, 2003; Houston et al. 2007). Pharmacologically, the enhancement of receptor function by certain general anaesthetics, anticonvulsants, neurosteroids and potentially ethanol is also influenced by the nature of the β subunit isoform (Belelli et al. 1997; Hill-Venning et al. 1997; Wallner et al. 2003; Shen et al. 2007).
We previously demonstrated that both synaptic and extrasynaptic receptors of thalamic ventrobasal (VB) neurones contain the β2 subunit (Belelli et al. 2005; Peden et al. 2008). DGGCs, in common with VB neurones, express extrasynaptic GABAA receptors composed of α4 and δ subunits, although the identity of the partner β subunit is not known. To characterize the synaptic and extrasynaptic GABAA receptors of DGGCs we have utilized an electrophysiological approach, in combination with mice genetically engineered to either lack specific GABAA receptor subunits (β2, α1, δ), or to express an etomidate-insensitive mutant β2 subunit (β2N265S).
We report that in contrast to thalamic VB neurones, the β2 subunit is not expressed at DGGC synapses and alternatively we present evidence for synaptic β3-GABAA receptors and the presence of a minor population of synaptic β1-GABAA receptors. However, in common with thalamic relay neurones, extrasynaptic diazepam-insensitive δ-GABAA receptors of DGGCs incorporate the β2 subunit. Therefore, the α4β2δ isoform is an important receptor subtype in two distinct neuronal populations. A component of the tonic current is mediated by diazepam-sensitive extrasynaptic receptors containing α5 and γ2 subunits (Zhang et al. 2007). In contrast to the extrasynaptic δ-GABAA receptors, we find that these extrasynaptic α5-GABAA receptors do not contain the β2 subunit.
In conclusion, within the neuronal cell soma of DGGCs, evidence is presented for the differential expression of β subunit isoforms, not only between the synaptic and extrasynaptic pools, but additionally within distinct populations of extrasynaptic receptors. The unambiguous identification of the subunit composition of these heterogeneous extrasynaptic receptors will be an important step in advancing our understanding of how their properties are tailored to act in concert with their synaptic counterparts to influence neuronal signalling in both physiological and pathophysiological scenarios.
Methods
The α1−/−, β2−/− and β2N265S mice were generated on a mixed C57BL6–129SvEv background at the Merck Sharp & Dohme Research Laboratories at the Neuroscience Research Centre in Harlow as previously described (Sur et al. 2001; Reynolds et al. 2003). The δ−/− mice were also generated on a mixed C57BL/6J–129Sv/SvJ background at the University of Pittsburgh as previously described (Mihalek et al. 1999). Experiments were conducted on slices prepared from the first two generations of WT, α1−/−, β2−/−, β2N265S and δ−/− breeding pairs derived from the corresponding heterozygous +/− mice bred at the University of Dundee.
Slice preparation
Hippocampal, or cerebellar slices were prepared from mice of either sex (P20–26) according to standard protocols as previously described (Belelli & Herd, 2003; Reynolds et al. 2003). Animals were killed by cervical dislocation in accordance with Schedule 1 of the UK Animals (Scientific Procedures) Act 1986. The brain was rapidly dissected and placed in oxygenated ice cold artificial cerebrospinal fluid (aCSF) solution containing (mm): 225 sucrose, 2.95 KCl, 1.25 NaH2PO4, 26 NaHCO3, 0.5 CaCl2, 10 MgSO4, 10 d-glucose (pH 7.4; 330–340 mosmol l−1). The tissue was maintained in ‘ice-cold’ aCSF. Hippocampal horizontal (300–350 μm thick), or cerebellar parasagittal (250 μm thick) slices were cut using a Vibratome (St Louis, MO, USA). The slices were incubated at room temperature in an oxygenated, extracellular solution (ECS) containing (mm): 126 NaCl, 2.95 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 10 d-glucose and 2 MgCl2 (pH 7.4; 300–310 mosmol l−1) for a minimum of 1 h prior to experimentation.
Electrophysiology
Whole-cell patch clamp recordings were performed at 35°C from DGGCs or Purkinje neurones visually identified with an Olympus BX51 (Olympus, Southall, UK) microscope equipped with DIC/IR optics. Patch electrodes were prepared from thick walled borosilicate glass (Garner Glass Co., Claremont, CA, USA) and had open tip resistances of 4–5 MΩ when filled with an intracellular solution that contained (mm): 135 CsCl, 10 Hepes, 10 EGTA, 2 Mg-ATP, 1 CaCl2, 1 MgCl2, 5 QX-314 (pH 7.3 with CsOH, 300–305 mosmol l−1). Miniature inhibitory postsynaptic currents (mIPSCs) were recorded using an Axopatch 1D or Axopatch 200B amplifier (Molecular Devices, Union City, CA, USA) at a holding potential of −60 mV in ECS additionally containing 2 mm kynurenic acid (Sigma-Aldrich, UK) and 0.5 μm tetrodotoxin (TTX; Tocris Bioscience, Bristol, UK) to block ionotropic glutamate receptors and sodium-dependent action potentials, respectively.
Drug application
R-(+)-Etomidate (3 × 10−3m), 4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridin-3-ol (THIP, gaboxadol; 10−3m) and bicuculline methobromide (3 × 10−2m) were prepared as concentrated aqueous stock solutions, whereas diazepam (10−3m) was dissolved in DMSO. Stock solutions (1000×) were diluted in ECS to the desired final concentration. The final maximum DMSO concentration (0.1%) had no effect on the properties of the mIPSCs, or tonic current (data not shown). All modulatory agents were applied via the perfusion system (2–4 ml min−1) and allowed to infiltrate the slice for a minimum of 10 min before recordings were acquired in the presence of the drug. With the exception of THIP, which was a generous gift of Dr Bjarke Ebert (Lundbeck), and etomidate (Organon), all drugs tested were obtained from either Sigma-Aldrich (Poole, Dorset, UK), or Tocris Bioscience (Bristol, UK).
Data analysis
Data were recorded onto a digital audio tape using a Biologic DTR 1200 recorder and analysed offline using the Strathclyde Electrophysiology Software, WinEDR/WinWCP (Belelli et al. 2005). Individual mIPSCs were detected using a low amplitude (−4 pA, 4 ms duration) threshold detection algorithm followed by visual scrutiny to avoid spurious detections. Accepted events were analysed for peak amplitude, 10–90% rise time, charge transfer and time for events to decay by 50% (T50) and 90% (T90). To minimize the contribution of dendritically generated currents, which are subject to cable filtering, the analysis was restricted to events with a rise time ≤ 1 ms. A minimum of 50 accepted events were digitally averaged by alignment at the mid-point of the rising phase, and the mIPSC decay fitted (98–5% of the peak amplitude) by either monoexponential (y(t) =Ae(−t/τ)), or biexponential (y(t) =A1e(−t/τ1)+A2e(−t/τ2)) functions using the least squares method, where A is amplitude, t is time and τ is the decay time constant. Analysis of the s.d. of residuals and use of the F test to compare goodness of fit revealed that the decay of the average mIPSC waveform was always best fitted with the sum of two exponential components. Thus, a weighted decay time constant (τw) was also calculated according to the equation: τw=τ1P1+τ2P2, where τ1 and τ2 are the decay time constants of the first and second exponents and P1 and P2 are the proportions of the synaptic current decay described by each function. The mIPSC frequency was determined over a 2 min recording period (20 s bins) with the EDR program using a detection method based on the rate of rise of the slowest events (35–40 pA ms−1) and subsequent visual scrutiny. The efficacy of the phasic current was calculated by multiplying the charge transfer associated with the mean individual mIPSC (QmIPSC) by the number of mIPSCs per unit of time (effectively the frequency).
The tonic current was calculated as the difference between the holding current before and after application of 30 μm bicuculline methobromide. The holding current and RMS (i.e. s.d.) were sampled every 51.2 ms over a 2 min period for each recording condition. At the sampling rate of 10 kHz, 512 baseline points for each 51.2 ms provided one data point. Epochs containing synaptic events or an unstable baseline were excluded from the analysis. A minimum of 100 data points were measured for each recording condition (i.e. in the absence and presence of drug). The significance of a drug effect upon the tonic conductance was calculated by a paired comparison of the holding current before and after drug application.
All results are reported as the arithmetic mean ± standard error of mean (s.e.m.). The properties of phasic (i.e. mIPSC properties) and tonic (i.e. RMS) GABAA receptor-mediated inhibition were not different between the WT strains originally generated at the Neuroscience Research Centre in Harlow and at the University of Pittsburgh and hence the data from both WT strains were pooled. When data are presented as normalized, the mean value is calculated by averaging the normalized change for each cell following drug application. Statistical significance of the data was assessed with Student/s t test (paired or unpaired), and repeated measures ANOVA (one- or two-way, RM ANOVA) followed post hoc by the Newman–Keuls test as appropriate, using the SigmaStat software package (Systat Software Inc., San Jose, CA, USA). The large sample approximation of the Kolmogorov–Smirnov (KS) test (SPSS, SPSS Inc., Chicago, IL, USA) was used to compare the distribution of individual mIPSC parameters. For a stringent comparison, the level of significance was set at P < 0.01 for KS tests.
Results
Extrasynaptic GABAA receptors of DGGCs
Deletion of the β2 subunit reduces the THIP-sensitive, but not the diazepam-sensitive, tonic conductance
Using bicuculline to define the resting tonic current (Itonic) this antagonist revealed an ITonic of −16.6 ± 2.7 pA (n = 14) in DGGCs derived from WT mice (P < 0.001, paired Student/s t test, Fig. 1A, left panel). Concomitantly, bicuculline (30 μm) reduced membrane (root mean square, RMS) noise from 4.2 ± 0.2 pA to 2.8 ± 0.1 pA (P < 0.001, paired t test). By comparison, for β2−/− granule cells, the outward current induced by 30 μm bicuculline was significantly reduced compared with WT (β2−/−ITonic=−7.5 ± 1.3 pA, n = 13, P < 0.01 versus WT; unpaired t test; Table 1, Fig. 1A, right panel and Fig. 1C). Similarly, the membrane noise of the β2−/− neurones was significantly lower than that of WT (β2−/−, 3.4 ± 0.2 pA, P < 0.01), which was now only modestly, albeit significantly reduced by bicuculline (2.6 ± 0.1 pA, P < 0.001, paired t test). These results suggest that a significant proportion of extrasynaptic receptors in DGGCs contain the β2 subunit (see also Discussion).
Figure 1. For DGGCs deletion of the β2 subunit decreases the tonic current and the THIP-induced current, but does not influence the enhancement of the current by diazepam.
A, whole-cell recordings obtained from exemplar DGGCs of WT (left panel) and β2−/− (right panel) mice before and after the bath application of bicuculline (30 μm). B, whole-cell recordings and the corresponding all-points histograms (normalized to the holding current recorded in the presence of bicuculline, right panel) obtained from DGGCs of WT (left panel) and β2−/− (right panel) mice under control conditions (black), in the presence of THIP (1 μm, white) and subsequent to the application of bicuculline (30 μm, grey). Application of 30 μm bicuculline (grey) reveals a GABAA receptor-mediated tonic current, which is significantly reduced by deletion of the β2 subunit. Note also the significant decrease in the magnitude of the THIP-evoked current upon deletion of the β2 subunit. C, bar graph summarizing the effect of the β2 subunit deletion upon the tonic current and the THIP and diazepam-evoked current. Note that the amplitude of the current evoked by diazepam (1 μm) is not influenced by deletion of the β2 subunit. Data were obtained from 5–14 cells. Error bars indicate the s.e.m.*P < 0.05, **P < 0.01, unpaired t test.
Table 1.
Summary of the properties of the phasic and tonic GABAAR-mediated transmission in mouse WT and β2−/− DGGCs
| WT | β2−/− | |
|---|---|---|
| Rise time (ms) | 0.37 ± 0.01 | 0.39 ± 0.02 |
| Peak amplitude (pA) | −68.8 ± 2.4 | −65.2 ± 3.9 |
| τw (ms) | 8.9 ± 0.4 | 10.3 ± 0.6 |
| Charge transfer (fC) | −582.4 ± 33.3 | −623.1 ± 43.4 |
| Frequency (Hz) | 3.2 ± 0.3 | 2.7 ± 0.6 |
| Tonic current (pA) | −16.6 ± 2.7 | −7.5 ± 1.3* |
| Phasic charge (fC) | −1864 | −1682 |
| Tonic charge (fC) | −16600 | −7500 |
| Tonic contribution to total charge transfer | 90% | 82% |
n = 13–29. *P < 0.05.
Tonic inhibition in dentate granule cells is mediated, at least in part, by peri- or extra-synaptic GABAA receptors composed of α4, β and δ subunits (Nusser & Mody, 2002; Stell & Mody, 2002; Farrant & Nusser, 2005; Chandra et al. 2006), although evidence for an additional population of α5βγ2 receptors has recently been presented (Zhang et al. 2007). Given that ITonic is reduced in β2−/− DGGCs, we considered whether this manipulation reduced the number of δ- and/or γ2-GABAA receptors. Therefore, we investigated the actions of the GABAA receptor agonist THIP on the ITonic of β2−/− DGGCs. THIP is selective for recombinant receptors lacking a γ subunit, e.g. extrasynaptic δ-GABAA receptors (Brown et al. 2002; Storustovu & Ebert, 2006), and, in agreement, this agonist selectively increases the ITonic of thalamic, hippocampal and cortical neurones known to express the δ subunit (Belelli et al. 2005; Cope et al. 2005; Maguire et al. 2005; Drasbek & Jensen, 2006). Consistent with previous studies, for WT DGGCs, THIP (1 μm) induced a significant inward current (WT, −38 ± 5 pA, n = 14, P < 0.001, paired t test; Fig. 1B and C) that was sensitive to bicuculline. However, in β2−/− mice, the inward current induced by 1 μm THIP was significantly reduced relative to WT (β2−/−, −19 ± 6 pA, n = 8 versus WT, P < 0.05, unpaired t test; Fig. 1B and C).
As mentioned above, recent observations have indicated a population of extrasynaptic α5βγ2 receptors in adult mouse DGGCs exposed to 5 μm GABA. To investigate the identity of the β subunit of these receptors the action of diazepam was compared between WT and β2−/− DGGCs. Diazepam (1 μm), in the presence of GABA (5 μm), produced a modest, albeit significant, inward current in both WT and β2−/− DGGCs (WT, −16.4 ± 6 pA, n = 6; β2−/−, −15.3 ± 2 pA, n = 5, P < 0.05 paired t test for both genotypes; Fig. 1C) but, in contrast to THIP, this effect was not significantly different between the two genotypes (P > 0.05, unpaired t test WT versusβ2−/−). In the absence of added GABA, diazepam produced an inward current of similar amplitude in WT DGGCs (WT, no added GABA, −13.1 ± 2 pA, n = 5, P > 0.05 versus WT with 5 μm GABA, unpaired t test) indicating that similar receptor isoforms are recruited under both experimental conditions.
Collectively, these results suggest the presence of extrasynaptic β2-GABAA receptors, which incorporate α4 and δ subunits, although, in agreement with Zhang et al. (2007), a diazepam-sensitive extrasynaptic isoform incorporating β1/3, α5 and γ2 subunits is also resident (see below).
The enhancement of the tonic current by etomidate is reduced by the β2N265S mutation
The deletion of the β2 subunit may induce compensatory gene transcription, which complicates interpretation of such experiments (Brickley et al. 2001; Sur et al. 2001; Ponomarev et al. 2006). Therefore, to investigate the veracity of the conclusions drawn from the β2 null experiments, we recorded from DGGCs derived from β2N265S‘knock-in’ mice. For these mice, the β2 protein is replaced by a mutant subunit, engineered to be less sensitive to the positive allosteric effects of the general anaesthetic etomidate (Belelli et al. 1997; Reynolds et al. 2003; Belelli et al. 2005). Importantly, the mutation is functionally silent, until challenged with etomidate and consequently a comparison of the actions of this general anaesthetic on neurones derived from WT and mutant mice can act as a ‘finger print’ to infer the presence of the β2 subunit.
In agreement with our studies on thalamic relay neurones (Belelli et al. 2005), the ITonic revealed by 30 μm bicuculline in β2N265S DGGCs was not significantly different from that of WT neurones (β2N265SITonic=−26 ± 8.3 pA, n = 6, P > 0.05 versus WT, unpaired t test; Fig. 2B), i.e. the mutation appears functionally silent. However, this manipulation greatly influenced the interaction of etomidate with the extrasynaptic receptors. In WT DGGCs, etomidate (3 μm) induced a bicuculline-sensitive inward current of −42 ± 5 pA (n = 5, P < 0.001, paired t test; Fig. 2A and B). For β2N265 neurones, the inward current induced by 3 μm etomidate was significantly reduced compared with WT (β2N265S, −23 ± 4 pA, P < 0.05 versus WT, unpaired t test; Fig. 2A and B).
Figure 2. The etomidate-induced increase of the tonic conductance is reduced for DGGCs derived from β2N265S mice.
A, whole-cell recordings and the corresponding all-points histograms (normalized to the holding current recorded in the presence of bicuculline) obtained from exemplar DGGCs of WT (left panel) and β2N265S (right panel) mice under control conditions (black), in the presence of etomidate (3 μm, white) and subsequent to the application of bicuculline (30 μm, grey). Application of 30 μm bicuculline (grey) reveals a GABAA receptor-mediated tonic current of similar magnitude in WT and β2N265S DGGCs. By contrast, note that the amplitude of the etomidate-evoked current is reduced in DGGCs of β2N265S compared with WT mice. B, bar graph summarizing the effect of the β2 subunit mutation upon the tonic current and the etomidate-evoked current. Data were obtained from 5–14 cells. Error bars indicate the s.e.m.*P < 0.05, unpaired t test.
Deleting the δ subunit reduces the tonic current and the effect of etomidate
The interpretation of the β2N265S experiments assumes the inward current induced by etomidate to be mediated, at least in part, by extrasynaptic δ-GABAA receptors (see Discussion). However, DGGCs express both extrasynaptic δ- and α5-GABAA receptors (Zhang et al. 2007), and the α5-GABAA receptors native to hippocampal CA1 neurones are highly sensitive to etomidate (Caraiscos et al. 2004; Cheng et al. 2006). We therefore compared the actions of this anaesthetic on the tonic current of DGGCs derived from WT and δ−/− mice. In agreement with others (Stell et al. 2003; Maguire et al. 2005), the outward current induced by 30 μm bicuculline was significantly reduced in δ−/− DGGCs compared with WT neurones (ITonic: WT, −16.6 ± 2.7 pA, n = 14; δ−/−, −6.2 ± 2.4 pA, n = 5, P < 0.05, unpaired t test; Fig. 3A and B). Additionally, the membrane RMS was significantly lower in recordings from δ−/− neurones (WT, 4.2 ± 0.2 pA; δ−/−, 3.0 ± 0.1 pA, P < 0.05, unpaired t test), reflecting a decreased number of extrasynaptic receptors. Indeed, the magnitude of the remaining tonic current of δ−/− neurones was not significantly different from that of β2−/− neurones (ITonic: β2−/−, −7.5 ± 1.3 pA, n = 13, P > 0.05 versusδ−/−, unpaired t test). Deletion of the δ subunit significantly reduced the inward current induced by 3 μm etomidate compared with WT neurones (WT, −42 ± 5 pA, n = 5; δ−/−, −17 ± 5 pA, n = 6, P < 0.01, unpaired t test; Fig. 3A and B). Collectively, these data propose that DGGCs, in common with thalamic VB neurones, express a population of extrasynaptic receptors composed of α4β2δ subunits.
Figure 3. Deletion of the δ subunit reduces the tonic current and the etomidate-induced increase of the tonic conductance of DGGCs.
A, whole-cell recordings and the corresponding all-points histograms (normalized to the holding current recorded in the presence of bicuculline) obtained from exemplar DGGCs of WT (left panel) and δ−/− (right panel) mice under control conditions (black), in the presence of etomidate (3 μm, white) and subsequent to the application of bicuculline (30 μm, grey). Application of 30 μm bicuculline (grey) reveals that the GABAA receptor-mediated tonic current of δ−/− DGGCs is significantly smaller versus WT DGGCs. Note that the amplitude of the etomidate-evoked current is also reduced in DGGCs of δ−/−versus WT mice. B, bar graph summarizing the effect of the δ subunit deletion upon the tonic current and the amplitude of the etomidate-evoked current. Data were obtained from 5–14 cells. Error bars indicate the s.e.m.**P < 0.01, unpaired t test.
Synaptic GABAA receptors of DGGCs
The mIPSCs of DGGCs occurred with a frequency of 3.2 ± 0.3 Hz, exhibited a peak amplitude of −68.8 ± 2.4 pA and decayed with a time constant (τW) of 8.9 ± 0.4 ms. Hence, considering the frequency and total charge passed per mIPSC, under these experimental conditions (i.e. TTX treated) the current mediated by the extrasynaptic receptors is dominant, contributing ∼90% of the total charge transferred (Table 1). As described above, DGGCs express a population of diazepam-sensitive extrasynaptic GABAA receptors. Additionally, in the presence of 5 μm GABA, diazepam (1 μm) prolonged the mIPSC decay of DGGCs, with no effect on their rise time, or amplitude (% increase, τw= 61 ± 7%, n = 6, P < 0.001, one-way RMA). As noted above, in common with the extrasynaptic conductance, the effect of diazepam on mIPSCs was not altered in the absence of added GABA (% increase, τw= 61 ± 9%, n = 5, P > 0.05 versus+ 5 μm GABA, two-way RMA). Hence, these synaptic receptors contain the γ2 subunit, coexpressed with the α1, α2, α3, or the α5 subunit. By contrast, although THIP (1 μm) activated a population of δ-GABAA receptors, it had no effect on the amplitude or kinetics of mIPSCs (% control, τw= 102 ± 2%, peak amplitude = 105 ± 2%, rise time = 103 ± 3%, n = 14, P > 0.05, one-way RMA).
The influence of deleting the β2 or the α1 subunit on DGGC mIPSCs
Deletion of the β2 subunit had no significant effect on the frequency (2.7 ± 0.6 Hz), peak amplitude (−65.2 ± 3.9 pA), or decay kinetics (τW= 10.3 ± 0.6 ms) of DGGC mIPSCs and consequently no influence on the charge carried by synaptic GABAA receptors (Fig. 4A; Table 1). However, given the considerable effect of deleting the β2 subunit on the tonic current (Fig. 1), this manipulation greatly reduced the total (i.e. synaptic + extrasynaptic) charge transferred by GABAA receptors by ∼50%, although given the dominant influence of the residual tonic conductance, extrasynaptic receptors still contributed ∼82% to the total charge transferred in β2−/− neurones (Table 1).
Figure 4. The effect of deletion of the β2 and α1 subunit upon the properties of DGGC mIPSCs.
A, representative, superimposed normalized ensemble averages of GABAAR mIPSCs recorded from WT (black) and β2−/− (grey) and B, WT (black) and α1−/− (grey) DGGCs. For comparison a representative, superimposed normalized ensemble average of GABAAR mIPSCs recorded from an exemplar WT Purkinje neurone (dotted line) is shown in B. Note that deletion of the β2 subunit does not affect any of the DGGC mIPSC properties, whereas deletion of the α1 subunit produces a modest prolongation of the decay kinetics.
Restriction of the β2 subunit to an extrasynaptic receptor pool may be a consequence of the absence of an appropriate subunit partner. In contrast to DGGCs, we have previously reported the β2 subunit deletion to greatly decrease the amplitude of mIPSCs of Purkinje and thalamocortical VB neurones (Haythornthwaite, 2004; Belelli et al. 2005). However, the synaptic GABAA receptors of these neurones incorporate the α1 subunit, i.e. α1β2γ2 GABAA receptors (Reynolds et al. 2003; Belelli et al. 2005; Kralic et al. 2006), the most prevalent subtype in the mammalian CNS (Whiting, 2003), whereas DGGCs express only relatively low levels of α1 subunit mRNA and protein (Wisden et al. 1992; Sperk et al. 1997; Hutcheon et al. 2004). In agreement, deletion of the α1 subunit had no effect on the frequency, peak amplitude, or rise time of DGGC mIPSCs, although these synaptic currents were modestly prolonged relative to WT mIPSCs (WT: τw= 9.9 ± 0.5 ms, n = 10; α1−/−: τw= 11.9 ± 0.6 ms, n = 15; P < 0.05, unpaired t test; see Fig. 4B for an exemplar neurone). Given that Purkinje neurone synapses contain α1β2γ2 GABAA receptors (Reynolds et al. 2003; Kralic et al. 2006), we determined the properties of their mIPSCs for comparison. Such mIPSCs decayed much more rapidly (τW= 3.1 ± 0.1 ms, n = 33 neurones) than those of DGGCs, consistent with synaptic expression of the α1 subunit (Fig. 4B; Kralic et al. 2006). Furthermore, in contrast to DGGCs, α1−/− Purkinje neurones were devoid of mIPSCs (not shown – see also Kralic et al. 2006). Thus, in conclusion, although the β2 subunit is clearly expressed extrasynaptically by DGGCs, it is conceivable that the lack of an appropriate α subunit partner precludes receptors incorporating this subunit to congregate at the synapse.
The influence of etomidate on the mIPSCs of WT and β2N265S DGGCs
The β2‘knock-out’ experiments suggest that DGGC synaptic GABAA receptors contain the β3 and/or the β1 subunit, coupled with the γ2 subunit (diazepam sensitive). Etomidate preferentially facilitates GABA responses mediated by β3 or β2 compared with β1 subunit containing receptors (Belelli et al. 1997; Hill-Venning et al. 1997). Here, 3 μm etomidate had no effect on the rise time, or frequency, of WT DGGC mIPSCs and only modestly increased their amplitude (11 ± 6% increase, P > 0.05, one-way RMA). However, this anaesthetic clearly prolonged the mIPSC decay (% increase, τW= 75 ± 12%n = 6, P < 0.001, one-way RMA – see Fig. 5). These data, together with the lack of effect on mIPSCs of deleting the β2 subunit, suggest the presence of synaptic β3-GABAA receptors.
Figure 5. The effect of etomidate to prolong mIPSCs is similar for DGGCs derived from WT and β2N265S mice.
A, representative, normalized superimposed ensemble averages of GABAAR mIPSCs from WT (left) and β2N265S (right) DGGCs recorded before (black) and after (grey) application of etomidate (3 μm). B, bar graph summarizing the effect of etomidate (3 μm) upon the mIPSC properties (normalized to percentage of control) of WT and β2N265S DGGCs. Data were obtained from 6–9 cells. Error bars indicate the s.e.m.**P < 0.01, ***P < 0.001, 1-way RM ANOVA.
Given that gene deletion may trigger compensatory changes, we additionally investigated the actions of etomidate on the mIPSCs of DGGCs derived from β2N265S mice. We have previously reported the effect of this anaesthetic on the decay phase of mIPSCs of cerebellar Purkinje and thalamic VB neurones to be blunted by this mutation (Reynolds et al. 2003; Belelli et al. 2005). In common with WT, 3 μm etomidate had no effect on the rise time, or frequency of mIPSCs recorded from β2N265S DGGCs and only caused a modest increase of amplitude (7 ± 3% increase, n = 9, P < 0.05, one-way RMA). However, the anaesthetic again produced a clear prolongation of their decay (% increase of τw= 78 ± 9%, n = 9, P < 0.001, one-way RMA – see Fig. 5), an effect not significantly different from that for WT neurones (WT versusβ2N265SP > 0.05, two-way RMA; Fig. 5B). Collectively, these data suggest the presence of synaptic β3-GABAA receptors.
To investigate whether all DGGC synaptic GABAA receptors are sensitive to etomidate, we determined the influence of this anaesthetic on individual mIPSC T90 values (the time taken for the mIPSC to decay from peak amplitude to 10% of peak). Cumulative probability plots of T90 values revealed a limited population of mIPSCs in all neurones tested that were insensitive to this concentration (3 μm) of etomidate (Fig. 6A, see shaded area). Similar results were obtained for β2N265S neurones (Fig. 6B). The presence of a population of synaptic GABAA receptors incorporating the β1 subunit provides a parsimonious explanation for these data.
Figure 6. A small population of DGGC mIPSCs are insensitive to the action of etomidate both in WT and β2N265S mice.
Cumulative probability plots of the T90 values of mIPSCs recorded before (black) and after application of 3 μm etomidate (grey) from DGGCs of WT (A) and β2N265S (B) mice. C, cumulative probability plots of the T90 values of mIPSCs recorded before (black) and after application of 30 μm pentobarbitone (grey) from WT DGGCs. The plots are constructed from T90 values obtained from 826 to 1586 mIPSCs collected from 6–9 representative DGGCs. The grey shaded area illustrates the area of overlap between the T90 distributions following etomidate, but not pentobarbitone application (T90 ≤ 10 ms; control versus 3 μm etomidate). Note that the mIPSCs occurring within this region were insensitive to etomidate. By contrast, pentobarbitone prolongs the decay of all DGGC mIPSCs.
In contrast to etomidate, the GABA-modulatory effects of anaesthetic barbiturates are not influenced by the isoform of the β subunit (Hill-Venning et al. 1997). Pentobarbitone (30 μm) produced a significant prolongation of the mIPSC decay (% increase of τw= 123 ± 3%, n = 7, P < 0.001, one-way RMA), but in contrast to etomidate, all mIPSCs were sensitive to this anaesthetic (Fig. 6C).
The effect of etomidate on DGGC mIPSCs is enhanced by deletion of the δ subunit
As described above, deletion of the δ subunit decreased extrasynaptic receptor expression in DGGCs and consequently greatly reduced the effect of etomidate. By contrast, etomidate-induced anaesthesia (loss of the righting reflex) is little influenced by this genetic manipulation (Mihalek et al. 1999). We therefore determined the effect of this anaesthetic on DGGC synaptic GABAA receptors. There were no significant differences in the properties of the mIPSCs of δ−/− DGGCs compared with WT. However, surprisingly etomidate (3 μm) was significantly more effective in prolonging the mIPSCs of δ−/− DGGCs than those of WT neurones (% increase τw, WT, 92 ± 12%, n = 7, P < 0.001, one-way RMA; δ−/−, 159 ± 20%, n = 9, P < 0.001, one-way RMA; WT versusδ−/−P < 0.001, two-way RMA, Fig. 7A and B). The mechanisms underlying this unexpected form of plasticity and the consequences for interpreting behavioural studies are discussed below.
Figure 7. The effect of etomidate to prolong DGGC mIPSCs is increased by deletion of the δ subunit.
A, representative, normalized superimposed ensemble averages of GABAAR mIPSCs from WT (left) and δ−/− (right) DGGCs recorded before (black) and after (grey) application of etomidate (3 μm). B, bar graph summarizing the normalized (expressed as percentage control) effect of etomidate (3 μm) upon the mIPSC properties of WT and δ−/− DGGCs. Note that deletion of the δ subunit significantly increased the etomidate-induced prolongation of the mIPSC decay. Data were obtained from 7–9 cells. Error bars indicate the s.e.m.***P < 0.001, 1-way RM ANOVA; †††P < 0.001, 2-way, RM ANOVA.
Discussion
The subunit composition of GABAA receptors influences their biophysical and pharmacological properties, dictates neuronal location and their interaction with associated proteins, and markedly influences the impact of intracellular biochemistry. In this regard, the nature of the β subunit isoform has received little consideration. DGGCs have both synaptic and extrasynaptic receptors and express all three β subunit isoforms (Wisden et al. 1992; Sperk et al. 1997; Miralles et al. 1999; Pirker et al. 2000). The present study reveals a highly specific designation of β subunits into synaptic, or extrasynaptic receptor pools, in an isoform-selective manner.
DGGC extrasynaptic GABAA receptors
Previous studies have revealed that deletion of either the α4 or the δ subunit greatly reduced the tonic current of DGGCs (Stell et al. 2003; Chandra et al. 2006), although the nature of the accompanying β subunit is not known. Immunocytochemistry reveals a diffuse labelling of the β2 subunit in DGGCs (Sperk et al. 1997), and in agreement here we report that deletion of the β2 subunit and, confirming earlier studies, the δ subunit greatly reduced both the magnitude and associated membrane noise of the tonic current of DGGCs. In DGGCs the inward current induced by the agonist THIP is attenuated by deletion of the δ subunit (Maguire et al. 2005) and here the effect of this agonist was also substantially reduced for neurones derived from β2−/− mice. Further proof that DGGCs express a population of extrasynaptic β2 subunit-containing receptors is provided by the effect of etomidate. This anaesthetic is selective for GABAA receptors containing either β2 or β3 subunits (Belelli et al. 1997; Hill-Venning et al. 1997). Here etomidate enhanced the tonic current and this effect was attenuated for DGGCs derived from mice expressing a mutant β2 subunit (β2N265S) engineered to be less sensitive to this anaesthetic (Reynolds et al. 2003; Belelli et al. 2005). Etomidate, by enhancing GABA sensitivity, may recruit additional populations of extrasynaptic GABAA receptors, as suggested for the actions of diazepam on hippocampal CA1 neurones (Prenosil et al. 2006). Therefore, it cannot be assumed that etomidate acts primarily on the same population(s) of extrasynaptic receptors that mediate the tonic current in the absence of the anaesthetic. However, the effect of etomidate on the tonic current was also substantially decreased by δ subunit deletion. Collectively, these studies suggest a significant component of the tonic conductance in DGGCs is mediated by the α4β2δ receptor isoform. Thalamic VB neurones express α4β2δ receptors (Belelli et al. 2005) and therefore this extrasynaptic receptor isoform appears to reside in two distinct neuronal populations.
A recent report revealed a component of the tonic current recorded from DGGCs (in the presence of GABA) to be enhanced by diazepam, an effect not evident in neurones derived from α5−/− mice, identifying an additional population of extrasynaptic GABAA receptors incorporating α5 and γ2 subunits (Zhang et al. 2007). Here we confirm this effect of diazepam, and additionally demonstrate the benzodiazepine enhancement of the tonic current to be evident either in the presence or absence of added GABA. As noted above, for both β2−/− and δ−/− DGGCs, there is a residual, albeit small, tonic current. Here, we report the tonic current of WT and β2−/− DGGCs to be similarly sensitive to diazepam, indicating that the benzodiazepine-induced enhancement of the tonic conductance is mediated by a population of extrasynaptic receptors that do not incorporate the β2 subunit, presumably α5β1/3γ2 receptors. Etomidate potently enhances the function of extrasynaptic α5-GABAA receptors of hippocampal CA1 neurones (Caraiscos et al. 2004; Cheng et al. 2006). Therefore, the residual etomidate-induced current evident in β2N265S neurones may result from an interaction with extrasynaptic α5β3γ2 receptors. However, the effect of etomidate on β2N265S neurones must be interpreted with caution, as the mutation does not completely abolish the enhancement of GABAA receptor function by this anaesthetic, nor are β1-GABAA receptors absolutely etomidate insensitive (Belelli et al. 1997, 2005; Hill-Venning et al. 1997; Reynolds et al. 2003).
Therefore, in common with hippocampal CA1 neurones (Caraiscos et al. 2004; Scimemi et al. 2005), DGGCs express distinct populations of benzodiazepine-insensitive (α4β2δ) and -sensitive (α5β1/3γ2) extrasynaptic receptors. However, additional extrasynaptic receptor isoforms may contribute. In particular, for β2−/− DGGCs a low concentration of THIP still induced an inward current, albeit reduced in amplitude in comparison to WT neurones. THIP is a potent agonist of δ subunit-containing GABAA receptors, and of receptors composed of only α and β subunits, but is a relatively ineffective agonist of γ2 subunit-containing receptors (Storustovu & Ebert, 2006). Consequently, it is unlikely that the residual effect of THIP in β2−/− DGGCs is mediated by the proposed diazepam-sensitive α5β1/3γ2 receptors and suggests the presence of a population of αβ1/3 or αβ1/3δ receptors.
In conclusion the extrasynaptic receptors of DGGCs are heterogeneous and a future challenge will be to understand how the properties of these distinct pools of receptors and their relative expression are tailored to act in concert to influence neuronal excitability.
DGGC synaptic GABAA receptors
The prolongation of WT mIPSCs by etomidate is indicative of synaptic GABAA receptors incorporating the β2 or β3 subunit. However, for each neurone, a small proportion of relatively ‘fast decaying’ etomidate-insensitive synaptic events were evident. Pentobarbitone does not discriminate between β subunit isoforms (Hill-Venning et al. 1997) and in contrast to etomidate, all DGGC mIPSCs were sensitive to this anaesthetic. These data advocate the presence of a limited population of ‘fast’ decaying mIPSCs mediated by synaptic β1-GABAA receptors. We previously demonstrated the effect of etomidate on mIPSCs recorded from Purkinje, or thalamic VB neurones derived from β2N265S mice to be greatly reduced (Reynolds et al. 2003; Belelli et al. 2005). However, the effects of this anaesthetic on β2N265S DGGC mIPSCs were indistinguishable from WT neurones, indicating a population of β3-GABAA synaptic receptors. Indeed, strong β3 subunit immunoreactivity is evident in these neurones (Sperk et al. 1997; Miralles et al. 1999; Pirker et al. 2000). Importantly, in contrast to Purkinje and VB neurones, the β2 subunit deletion had no effect on DGGC mIPSCs (Haythornthwaite, 2004; Belelli et al. 2005).
Adding complexity, immunoprecipitation studies suggest a substantial proportion of hippocampal GABAA receptors may contain two different β subunit isoforms within the pentamer (Li & De Blas, 1997). Recombinant receptors incorporating β1 with β3 or β2 subunits appear pharmacologically similar to β1-GABAA receptors (relatively insensitive to loreclezole, or etomidate –Fisher & Macdonald, 1997; Boulineau et al. 2005).
Therefore, in conclusion, DGGC inhibitory synapses predominantly contain β3-GABAA receptors that mediate relatively slowly decaying mIPSCs. Evidence is presented for a minor population of synaptic receptors composed of β1 or potentially β1 and β3 subunits that mediate relatively fast decaying mIPSCs. Interestingly, thalamic reticular neurones exhibit two kinetically distinct populations of mIPSCs, which based on their differential sensitivity to loreclezole, also appear to be due to activation of synaptic β1- and β3-GABAA receptors (Huntsman & Huguenard, 2006). Although DGGCs express the β2 subunit, it appears to be restricted to a particular pool (α4β2δ) of extrasynaptic receptors. These data contrast with thalamic VB neurones, where β2-GABAA receptors are expressed both extrasynaptically (α4β2δ) and synaptically (α1β2γ2–Belelli et al. 2005; Peden et al. 2008). The differential distribution of the β2 subunit in DGGCs is intriguing given that synaptic GABAA receptors are highly mobile, being recruited from, and dynamically interacting with, the extrasynaptic receptor pool (Thomas et al. 2005; Bogdanov et al. 2006; Charrier et al. 2006).
The exclusion of the β2 subunit from the synapse may be a consequence of the lack of an appropriate α subunit partner. Although for recombinant receptors the β2 subunit associates indiscriminately with various α subunits, in certain neurones it preferentially coassembles with α1 and γ2 subunits (Sur et al. 2001; Fritschy & Brunig, 2003; Whiting, 2003; Mohler, 2007). However, in the dentate gyrus, the expression of the α1 subunit is limited, whereas the α2 subunit, which preferentially coassembles with β3 and γ2 subunits, exhibits strong immunoreactivity and a clear synaptic localization (Fritschy & Mohler, 1995; Sperk et al. 1997; Fritschy & Brunig, 2003; Ramadan et al. 2003; Wei et al. 2003; Mohler, 2007). Furthermore, as reported here, deletion of the α1 subunit only modestly influenced the mIPSC decay. Thus, a preferential association of the α2 subunit with the β3 and possibly the β1 subunit may result in the exclusion of the β2 subunit from DGGC synapses.
The β subunit isoform influences receptor expression and function
An array of GABAA receptor associated proteins may regulate receptor trafficking, membrane stabilization and internalization and consequently influence neuronal excitability (Michels & Moss, 2007; Chen & Olsen, 2007). Many such interactions occur via an association with the large intracellular loop of the β subunit, a portion of the protein that differs substantially across the β subunit isoforms. As some interactions are β-subtype-specific, given the discrete subcellular distribution of β subunits in DGGCs, these associated proteins may differentially impact on tonic and phasic transmission.
The activity of resident kinases and phosphatases influence GABAA receptor function and trafficking and may modify the response to allosteric modulators such as alcohol, benzodiazepines and neurosteroids (Hodge et al. 1999; Kittler & Moss, 2003; Herd et al. 2007; Qi et al. 2007). The large intracellular loop of the β subunit contains consensus sites for phosphorylation by several kinases and incorporates binding domains for intracellular proteins that influence kinase activity (Kittler & Moss, 2003; Houston et al. 2007). Importantly, both the association of such proteins, the kinase/phosphorylation profile and the functional consequences of phosphorylation are β isoform specific. For example, for β3 or β1 subunits a homologous serine residue can be phosphorylated by α-CAMK-II, whereas the β2 subunit does not contain this site and consequently β2-GABAA receptors are insensitive to α-CAMK-II-dependent modulation (Houston et al. 2007). Clearly, future studies comparing the impact of manipulating neuronal kinase/phosphatase activity on extrasynaptic and synaptic receptor function and pharmacology in DGGCs will be of interest.
The β subunit isoform influences GABAA receptor pharmacology
The use of β subunit ‘knock-in’ mice has revealed that β2- and β3-GABAA receptors mediate distinct components of the behavioural repertoire produced by the general anaesthetic etomidate and the anticonvulsant loreclezole (Jurd et al. 2003; Reynolds et al. 2003; Cirone et al. 2004; Zeller et al. 2005; Groves et al. 2006). Extrasynaptic δ-GABAA receptors are proposed targets for general anaesthetics, neurosteroids, ethanol and THIP (Stell et al. 2003; Wallner et al. 2003; Wei et al. 2003; Hanchar et al. 2005; Belelli et al. 2005). Indeed, although both synaptic and extrasynaptic GABAA receptors of WT DGGCs are sensitive to etomidate, given the dominant influence (∼90%) of the tonic conductance, ∼99% of the anaesthetic-induced increase in the total charge transfer is mediated by extrasynaptic receptors. A similar differential effect of etomidate occurs in thalamic VB neurones (Belelli et al. 2005). The sedative effect of the anaesthetic is blunted in β2N265S mice (Reynolds et al. 2003). However, this mutation did not influence the effect of the anaesthetic on DGGC synaptic GABAA receptors, but considerably reduced (∼50%) the etomidate enhancement of the tonic conductance. Deletion of the δ subunit suppressed extrasynaptic receptor expression and therefore reduced (by ∼59%) the effect of the anaesthetic on the tonic conductance. In agreement with others (Wei et al. 2003), we found δ-GABAA receptors to have little influence on DGGC mIPSCs (at physiological temperature). However, unexpectedly, etomidate was significantly more effective in prolonging the mIPSCs of δ−/− DGGCs. By contrast, neurosteroid modulation of cerebellar granule cell (CGC) sIPSCs is reduced by δ subunit deletion, a scenario reversed by stimulation of PKC (Vicini et al. 2002). Whether the enhanced effect of etomidate on synaptic receptors is similarly a consequence of perturbations in phosphorylation, or alternatively, is due primarily to changes in the proportion of β3 to β1 synaptic GABAA receptors is not known. Clearly, such plasticity warrants caution for interpretation of behavioural studies in δ−/− mice.
The influence of the β isoform on receptor pharmacology is not restricted to general anaesthetics. Although the results of studies on the interaction of ethanol with δ-GABAA receptors are controversial (Lovinger & Homanics, 2007), the effect of this alcohol on CGC extrasynaptic receptors is reportedly favoured by δ-GABAA receptors incorporating β3 compared with β2 subunits (Hanchar et al. 2005). Furthermore, under conditions designed to mimic physiological intracellular chloride, neurosteroids reportedly inhibit GABA-evoked outward current responses mediated by α4β2δ receptors, but enhance equivalent responses mediated by α4β3δ receptors (Shen et al. 2007).
In conclusion, within the neuronal cell soma of DGGCs the β2 subunit is selectively incorporated into a pool of benzodiazepine-insensitive extrasynaptic (α4β2δ) receptors, but is not resident in populations of benzodiazepine-sensitive extrasynaptic (α5β1/3γ2) and synaptic receptors. To date our appreciation of the distinguishing properties of β subunit isoforms is somewhat rudimentary. However, it is already evident that the nature of the β subunit may influence receptor expression, biochemical control of receptor function and the pharmacology of the receptor. The categorical identification of GABAA receptor isoforms within a neurone should aid future studies aimed at determining how these pools of distinct GABAA receptors act in unison to influence DGGC excitability. Furthermore, such studies may be pertinent in aiding our understanding of certain neurological disorders, given that perturbations of DGGC GABA-ergic transmission have been reported in rodent models of Alzheimer/s disease, Down/s syndrome, anxiety, stress and epilepsy (Brooks-Kayal et al. 1998; Kleschevnikov et al. 2004; Maguire et al. 2005; Palop et al. 2007).
Acknowledgments
This work was supported by a BBSRC project grant, a BBSRC Case Award, Tenovus Tayside and the Anonymous Trust (J.J.L. and D.B.), and NIH (G.E.H.).
References
- Belelli D, Herd MB. The contraceptive agent Provera enhances GABAA receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? J Neurosci. 2003;23:10013–10020. doi: 10.1523/JNEUROSCI.23-31-10013.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ. The interaction of the general anesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci U S A. 1997;94:11031–11036. doi: 10.1073/pnas.94.20.11031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belelli D, Peden DR, Rosahl TW, Wafford KA, Lambert JJ. Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics. J Neurosci. 2005;25:11513–11520. doi: 10.1523/JNEUROSCI.2679-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bogdanov Y, Michels G, Armstrong-Gold C, Haydon PG, Lindstrom J, Pangalos M, Moss SJ. Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts. EMBO J. 2006;25:4381–4389. doi: 10.1038/sj.emboj.7601309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boulineau N, Baur R, Minier F, Sigel E. Consequence of the presence of two different β subunit isoforms in a GABAA receptor. J Neurochem. 2005;95:1724–1731. doi: 10.1111/j.1471-4159.2005.03495.x. [DOI] [PubMed] [Google Scholar]
- Brandon NJ, Jovanovic JN, Colledge M, Kittler JT, Brandon JM, Scott JD, Moss SJ. A-kinase anchoring protein 79/150 facilitates the phosphorylation of GABAA receptors by cAMP-dependent protein kinase via selective interaction with receptor β subunits. Mol Cell Neurosci. 2003;22:87–97. doi: 10.1016/s1044-7431(02)00017-9. [DOI] [PubMed] [Google Scholar]
- Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature. 2001;409:88–92. doi: 10.1038/35051086. [DOI] [PubMed] [Google Scholar]
- Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy. Nat Med. 1998;4:1166–1172. doi: 10.1038/2661. [DOI] [PubMed] [Google Scholar]
- Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA. Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. Br J Pharmacol. 2002;136:965–974. doi: 10.1038/sj.bjp.0704795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caraiscos VB, Elliott EM, You T, Cheng VY, Belelli D, Newell JG, Jackson MF, Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF, Orser BA. Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A. 2004;101:3662–3667. doi: 10.1073/pnas.0307231101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chandra D, Jia F, Liang J, Peng Z, Suryanarayanan A, Werner DF, Spigelman I, Houser CR, Olsen RW, Harrison NL, Homanics GE. GABAA receptor α4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A. 2006;103:15230–15235. doi: 10.1073/pnas.0604304103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charrier C, Ehrensperger MV, Dahan M, Levi S, Triller A. Cytoskeleton regulation of glycine receptor number at synapses and diffusion in the plasma membrane. J Neurosci. 2006;26:8502–8511. doi: 10.1523/JNEUROSCI.1758-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen ZW, Olsen RW. GABAA receptor associated proteins: a key factor regulating GABA receptor function. J Neurochem. 2007;100:279–294. doi: 10.1111/j.1471-4159.2006.04206.x. [DOI] [PubMed] [Google Scholar]
- Cheng VY, Martin LJ, Elliott EM, Kim JH, Mount HT, Taverna FA, Roder JC, MacDonald JF, Bhambri A, Collinson N, Wafford KA, Orser BA. α5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate. J Neurosci. 2006;26:3713–3720. doi: 10.1523/JNEUROSCI.5024-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cirone J, Rosahl TW, Reynolds DS, Newman RJ, O/Meara GF, Hutson PH, Wafford KA. γ-Aminobutyric acid type A receptor β2 subunit mediates the hypothermic effect of etomidate in mice. Anesthesiology. 2004;100:1438–1445. doi: 10.1097/00000542-200406000-00016. [DOI] [PubMed] [Google Scholar]
- Cope DW, Hughes SW, Crunelli V. GABAA receptor-mediated tonic inhibition in thalamic neurons. J Neurosci. 2005;25:11553–11563. doi: 10.1523/JNEUROSCI.3362-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Devor A, Fritschy JM, Yarom Y. Spatial distribution and subunit composition of GABAA receptors in the inferior olivary nucleus. J Neurophysiol. 2001;85:1686–1696. doi: 10.1152/jn.2001.85.4.1686. [DOI] [PubMed] [Google Scholar]
- Drasbek KR, Jensen K. THIP, a hypnotic and antinociceptive drug, enhances an extrasynaptic GABAA receptor-mediated conductance in mouse neocortex. Cereb Cortex. 2006;16:1134–1141. doi: 10.1093/cercor/bhj055. [DOI] [PubMed] [Google Scholar]
- Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat Rev Neurosci. 2005;6:215–229. doi: 10.1038/nrn1625. [DOI] [PubMed] [Google Scholar]
- Fisher JL, Macdonald RL. Functional properties of recombinant GABAA receptors composed of single or multiple β subunit subtypes. Neuropharmacology. 1997;36:1601–1610. doi: 10.1016/s0028-3908(97)00133-0. [DOI] [PubMed] [Google Scholar]
- Fritschy JM, Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther. 2003;98:299–323. doi: 10.1016/s0163-7258(03)00037-8. [DOI] [PubMed] [Google Scholar]
- Fritschy JM, Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol. 1995;359:154–194. doi: 10.1002/cne.903590111. [DOI] [PubMed] [Google Scholar]
- Glykys J, Peng Z, Chandra D, Homanics GE, Houser CR, Mody I. A new naturally occurring GABAA receptor subunit partnership with high sensitivity to ethanol. Nat Neurosci. 2007;10:40–48. doi: 10.1038/nn1813. [DOI] [PubMed] [Google Scholar]
- Groves JO, Guscott MR, Hallett DJ, Rosahl TW, Pike A, Davies A, Wafford KA, Reynolds DS. The role of GABA β2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole. Eur J Neurosci. 2006;24:167–174. doi: 10.1111/j.1460-9568.2006.04890.x. [DOI] [PubMed] [Google Scholar]
- Hanchar HJ, Dodson PD, Olsen RW, Otis TS, Wallner M. Alcohol-induced motor impairment caused by increased extrasynaptic GABAA receptor activity. Nat Neurosci. 2005;8:339–345. doi: 10.1038/nn1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haythornthwaite AR. University of Dundee; 2004. The GABAA receptor: a target for general anaesthetics. PhD Thesis. [Google Scholar]
- Herd MB, Belelli D, Lambert JJ. Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors. Pharmacol Ther. 2007;116:20–34. doi: 10.1016/j.pharmthera.2007.03.007. [DOI] [PubMed] [Google Scholar]
- Hill-Venning C, Belelli D, Peters JA, Lambert JJ. Subunit-dependent interaction of the general anaesthetic etomidate with the γ-aminobutyric acid type A receptor. Br J Pharmacol. 1997;120:749–756. doi: 10.1038/sj.bjp.0700927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF, Wang D, Sanchez-Perez AM, Messing RO. Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCɛ. Nat Neurosci. 1999;2:997–1002. doi: 10.1038/14795. [DOI] [PubMed] [Google Scholar]
- Houston CM, Lee HH, Hosie AM, Moss SJ, Smart TG. Identification of the sites for CaMK-II-dependent phosphorylation of GABAA receptors. J Biol Chem. 2007;282:17855–17865. doi: 10.1074/jbc.M611533200. [DOI] [PubMed] [Google Scholar]
- Huntsman MM, Huguenard JR. Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor β1 subunit. J Physiol. 2006;572:459–475. doi: 10.1113/jphysiol.2006.106617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hutcheon B, Fritschy JM, Poulter MO. Organization of GABA receptor α-subunit clustering in the developing rat neocortex and hippocampus. Eur J Neurosci. 2004;19:2475–2487. doi: 10.1111/j.0953-816X.2004.03349.x. [DOI] [PubMed] [Google Scholar]
- Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F, Zaugg M, Vogt KE, Ledermann B, Antkowiak B, Rudolph U. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit. FASEB J. 2003;17:250–252. doi: 10.1096/fj.02-0611fje. [DOI] [PubMed] [Google Scholar]
- Kittler JT, Moss SJ. Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr Opin Neurobiol. 2003;13:341–347. doi: 10.1016/s0959-4388(03)00064-3. [DOI] [PubMed] [Google Scholar]
- Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci. 2004;24:8153–8160. doi: 10.1523/JNEUROSCI.1766-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kralic JE, Sidler C, Parpan F, Homanics GE, Morrow AL, Fritschy JM. Compensatory alteration of inhibitory synaptic circuits in cerebellum and thalamus of γ-aminobutyric acid type A receptor α1 subunit knockout mice. J Comp Neurol. 2006;495:408–421. doi: 10.1002/cne.20866. [DOI] [PubMed] [Google Scholar]
- Li M, De Blas AL. Coexistence of two β subunit isoforms in the same γ-aminobutyric acid type A receptor. J Biol Chem. 1997;272:16564–16569. doi: 10.1074/jbc.272.26.16564. [DOI] [PubMed] [Google Scholar]
- Lovinger DM, Homanics GE. Tonic for what ails us? High-affinity GABAA receptors and alcohol. Alcohol. 2007;41:139–143. doi: 10.1016/j.alcohol.2007.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luscher B, Keller CA. Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacol Ther. 2004;102:195–221. doi: 10.1016/j.pharmthera.2004.04.003. [DOI] [PubMed] [Google Scholar]
- Maguire JL, Stell BM, Rafizadeh M, Mody I. Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci. 2005;8:797–804. doi: 10.1038/nn1469. [DOI] [PubMed] [Google Scholar]
- Michels G, Moss SJ. GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol. 2007;42:3–14. doi: 10.1080/10409230601146219. [DOI] [PubMed] [Google Scholar]
- Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, DeLorey TM, Olsen RW, Homanics GE. Attenuated sensitivity to neuroactive steroids in γ-aminobutyrate type A receptor δ subunit knockout mice. Proc Natl Acad Sci U S A. 1999;96:12905–12910. doi: 10.1073/pnas.96.22.12905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miralles CP, Li M, Mehta AK, Khan ZU, De Blas AL. Immunocytochemical localization of the β3 subunit of the γ-aminobutyric acidA receptor in the rat brain. J Comp Neurol. 1999;413:535–548. [PubMed] [Google Scholar]
- Mohler H. Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptors. J Neurochem. 2007;102:1–12. doi: 10.1111/j.1471-4159.2007.04454.x. [DOI] [PubMed] [Google Scholar]
- Nusser Z, Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol. 2002;87:2624–2628. doi: 10.1152/jn.2002.87.5.2624. [DOI] [PubMed] [Google Scholar]
- Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci. 1998;18:1693–1703. doi: 10.1523/JNEUROSCI.18-05-01693.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer/s disease. Neuron. 2007;55:697–711. doi: 10.1016/j.neuron.2007.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peden DR, Petitjean C, Herd MB, Durakoglugil M, Rosahl TW, Wafford KA, Homanics GE, Belelli D, Fritschy J-M, Lambert JJ. Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse ventrobasal neurones. J Physiol. 2008;586:965–987. doi: 10.1113/jphysiol.2007.145375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G. GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience. 2000;101:815–850. doi: 10.1016/s0306-4522(00)00442-5. [DOI] [PubMed] [Google Scholar]
- Ponomarev I, Maiya R, Harnett MT, Schafer GL, Ryabinin AE, Blednov YA, Morikawa H, Boehm SL, Homanics GE, Berman AE, Lodowski KH, Bergeson SE, Harris RA. Transcriptional signatures of cellular plasticity in mice lacking the α1 subunit of GABAA receptors. J Neurosci. 2006;26:5673–5683. doi: 10.1523/JNEUROSCI.0860-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prenosil GA, Schneider Gasser EM, Rudolph U, Keist R, Fritschy JM, Vogt KE. Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol. 2006;96:846–857. doi: 10.1152/jn.01199.2005. [DOI] [PubMed] [Google Scholar]
- Qi ZH, Song M, Wallace MJ, Wang D, Newton PM, McMahon T, Chou WH, Zhang C, Shokat KM, Messing RO. Protein kinase Cɛ regulates GABAA receptor sensitivity to ethanol and benzodiazepines through phosphorylation of γ2 subunits. J Biol Chem. 2007;282:33052–33063. doi: 10.1074/jbc.M707233200. [DOI] [PubMed] [Google Scholar]
- Ramadan E, Fu Z, Losi G, Homanics GE, Neale JH, Vicini S. GABAA receptor β3 subunit deletion decreases α2/3 subunits and IPSC duration. J Neurophysiol. 2003;89:128–134. doi: 10.1152/jn.00700.2002. [DOI] [PubMed] [Google Scholar]
- Reynolds DS, Rosahl TW, Cirone J, O/Meara GF, Haythornthwaite A, Newman RJ, Myers J, Sur C, Howell O, Rutter AR, Atack J, Macaulay AJ, Hadingham KL, Hutson PH, Belelli D, Lambert JJ, Dawson GR, McKernan R, Whiting PJ, Wafford KA. Sedation and anesthesia mediated by distinct GABAA receptor isoforms. J Neurosci. 2003;23:8608–8617. doi: 10.1523/JNEUROSCI.23-24-08608.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scimemi A, Semyanov A, Sperk G, Kullmann DM, Walker MC. Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci. 2005;25:10016–10024. doi: 10.1523/JNEUROSCI.2520-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shen H, Gong QH, Aoki C, Yuan M, Ruderman Y, Dattilo M, Williams K, Smith SS. Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty. Nat Neurosci. 2007;10:469–477. doi: 10.1038/nn1868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sperk G, Schwarzer C, Tsunashima K, Fuchs K, Sieghart W. GABAA receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits. Neuroscience. 1997;80:987–1000. doi: 10.1016/s0306-4522(97)00146-2. [DOI] [PubMed] [Google Scholar]
- Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors. Proc Natl Acad Sci U S A. 2003;100:14439–14444. doi: 10.1073/pnas.2435457100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stell BM, Mody I. Receptors with different affinities mediate phasic and tonic GABAA conductances in hippocampal neurons. J Neurosci. 2002;22:RC223. doi: 10.1523/JNEUROSCI.22-10-j0003.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Storustovu SI, Ebert B. Pharmacological characterization of agonists at δ-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of γ2. J Pharmacol Exp Ther. 2006;316:1351–1359. doi: 10.1124/jpet.105.092403. [DOI] [PubMed] [Google Scholar]
- Sur C, Farrar SJ, Kerby J, Whiting PJ, Atack JR, McKernan RM. Preferential coassembly of α4 and δ subunits of the γ-aminobutyric acidA receptor in rat thalamus. Mol Pharmacol. 1999;56:110–115. doi: 10.1124/mol.56.1.110. [DOI] [PubMed] [Google Scholar]
- Sur C, Wafford KA, Reynolds DS, Hadingham KL, Bromidge F, Macaulay A, Collinson N, O/Meara G, Howell O, Newman R, Myers J, Atack JR, Dawson GR, McKernan RM, Whiting PJ, Rosahl TW. Loss of the major GABAA receptor subtype in the brain is not lethal in mice. J Neurosci. 2001;21:3409–3418. doi: 10.1523/JNEUROSCI.21-10-03409.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas P, Mortensen M, Hosie AM, Smart TG. Dynamic mobility of functional GABAA receptors at inhibitory synapses. Nat Neurosci. 2005;8:889–897. doi: 10.1038/nn1483. [DOI] [PubMed] [Google Scholar]
- Vicini S, Losi G, Homanics GE. GABAA receptor δ subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology. 2002;43:646–650. doi: 10.1016/s0028-3908(02)00126-0. [DOI] [PubMed] [Google Scholar]
- Walker MC, Semyanov A. Regulation of excitability by extrasynaptic GABAA receptors. Res Probl Cell Differ. 2007 doi: 10.1007/400_2007_030. doi: 10.1007/400_2007_30. [DOI] [PubMed] [Google Scholar]
- Wallner M, Hanchar HJ, Olsen RW. Ethanol enhances α4β3δ and α6β3δγ-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci U S A. 2003;100:15218–15223. doi: 10.1073/pnas.2435171100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wei W, Zhang N, Peng Z, Houser CR, Mody I. Perisynaptic localization of δ subunit-containing GABAA receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci. 2003;23:10650–10661. doi: 10.1523/JNEUROSCI.23-33-10650.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whiting PJ. GABAA receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today. 2003;8:445–450. doi: 10.1016/s1359-6446(03)02703-x. [DOI] [PubMed] [Google Scholar]
- Wisden W, Laurie DJ, Monyer H, Seeburg PH. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci. 1992;12:1040–1062. doi: 10.1523/JNEUROSCI.12-03-01040.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zeller A, Arras M, Lazaris A, Jurd R, Rudolph U. Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol. FASEB J. 2005;19:1677–1679. doi: 10.1096/fj.04-3443fje. [DOI] [PubMed] [Google Scholar]
- Zhang N, Wei W, Mody I, Houser CR. Altered localization of GABAA receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci. 2007;27:7520–7531. doi: 10.1523/JNEUROSCI.1555-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]







